- Home
- DBD vs TVTX Comparison
DBD vs TVTX Comparison
Compare DBD & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBD
- TVTX
- Stock Information
- Founded
- DBD 1859
- TVTX 2008
- Country
- DBD United States
- TVTX United States
- Employees
- DBD N/A
- TVTX N/A
- Industry
- DBD EDP Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- DBD Technology
- TVTX Health Care
- Exchange
- DBD Nasdaq
- TVTX Nasdaq
- Market Cap
- DBD N/A
- TVTX 1.9B
- IPO Year
- DBD N/A
- TVTX N/A
- Fundamental
- Price
- DBD $44.06
- TVTX $17.44
- Analyst Decision
- DBD Strong Buy
- TVTX Strong Buy
- Analyst Count
- DBD 2
- TVTX 13
- Target Price
- DBD $65.00
- TVTX $33.08
- AVG Volume (30 Days)
- DBD 122.9K
- TVTX 1.5M
- Earning Date
- DBD 05-01-2025
- TVTX 05-05-2025
- Dividend Yield
- DBD N/A
- TVTX N/A
- EPS Growth
- DBD N/A
- TVTX N/A
- EPS
- DBD N/A
- TVTX N/A
- Revenue
- DBD $3,751,100,000.00
- TVTX $233,175,000.00
- Revenue This Year
- DBD $1.73
- TVTX $71.39
- Revenue Next Year
- DBD $1.60
- TVTX $55.24
- P/E Ratio
- DBD N/A
- TVTX N/A
- Revenue Growth
- DBD N/A
- TVTX 60.55
- 52 Week Low
- DBD $30.37
- TVTX $5.12
- 52 Week High
- DBD $51.81
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- DBD 52.56
- TVTX 34.91
- Support Level
- DBD $42.48
- TVTX $20.29
- Resistance Level
- DBD $45.31
- TVTX $20.98
- Average True Range (ATR)
- DBD 1.37
- TVTX 1.00
- MACD
- DBD 0.13
- TVTX -0.23
- Stochastic Oscillator
- DBD 67.45
- TVTX 2.01
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.